Subcutaneous implantable cardioverter-defibrillator in prevention of sudden cardiac death in Poland — opinion paper endorsed by the Polish Cardiac Society Working Group on Heart RhythmPaweł Ptaszyński, Maciej Sterliński, Marcin Grabowski et al.|Kardiologia Polska|2017Cited by 7
Multicentre early experience with totally subcutaneous cardioverter-defibrillators in PolandKrzysztof Kaczmarek, Paweł Ptaszyński, Maciej Kempa et al.|Archives of Medical Science|2019Cited by 5
Wearable cardioverter-defibrillator use in clinical settings in Poland: Nationwide observational cohort studyMaciej Sterliński, Jerzy Krzysztof Wranicz, Andrzej Przybylski et al.|Kardiologia Polska|2025Cited by 5
Smartphone App-Based Remote Monitoring Challenges in Patients with Cardiac Resynchronization Therapy Defibrillators—A Multicenter StudyDagmar Kowal, Przemysław Mitkowski, Elżbieta Wabich et al.|Journal of Clinical Medicine|2024Cited by 2
Cost-utility analysis of the use of a wearable cardioverter defibrillator (LifeVest®) versus standard of care in the prevention of sudden cardiac death in patients after myocardial infarctionPrzemysław Mitkowski, Dominik Golicki, Iwona Dobrowolska et al.|Kardiologia Polska|2025Cited by 1